NEW YORK (GenomeWeb) – Atum, formerly DNA2.0, announced today that it has licensed its novel gene design platform to Thermo Fisher Scientific.

Atum released Gene Designer 2.0 software in 2005. According to the firm, the technology captures the entire gene design process in one efficient application, using a range of design tools including various algorithms for in silico cloning, codon optimization, and primer design, as well as customizable database storage.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.